Page 16 - Sylvia Wimmer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-Adhoc : Heidelberg Pharma AG to Raise Capital in a Private Placement

DGAP-Adhoc : Heidelberg Pharma AG to Raise Capital in a Private Placement
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDietmar hoppHeidelberg pharmaEnglish companyGarnier coFinancial servicesFrankfurt stock exchangeDistribution servicesGmbh coTradegate exchangeNews serviceRaise capitalPrivate placementExecutive management boardSupervisory board

Investegate |Heidelberg Pharma AG Announcements | Heidelberg Pharma AG: Heidelberg Pharma AG Raises EUR 20 Million From Private Placement

Investegate |Heidelberg Pharma AG Announcements | Heidelberg Pharma AG: Heidelberg Pharma AG Raises EUR 20 Million From Private Placement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSylvia wimmerDietmar hoppHeidelberg pharmaMc servicesGarnier coFinancial servicesPolar capital biotech investment fundFrankfurt stock exchangeDistribution servicesFrom privateInvestments gmbhExecutive management boardSupervisory boardSole global coordinator

Heidelberg Pharma AG: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolut

Heidelberg Pharma AG: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolut
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Sylvia wimmerJan schmidtHeidelberg pharmaMc servicesArticles of associationCorporate communicationsFrankfurt stock exchangeDistribution servicesGeneral meetingHeidelberg pharma approves all proposedAnnual general meetingExecutive management boardSupervisory boardConditional capitalExecutive managementJan schmidt brand

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021

29.04.2021 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

Red hillNorth somersetUnited kingdomUnited statesCity ofMerck seronoSylvia wimmerJan schmidtMathias locherHeidelberg pharmaDevelopment officerSchool of medicineMd anderson cancer centerJanssen pharmaceutical companies of johnsonJj innovation centreMc services

PRESS RELEASE : Heidelberg Pharma AG: Interim -2-

Message : Required fields quarter of fiscal year 2021 compared to the prior-year period (EUR 0.8 million). Among others, this figure includes holding company costs and costs related to the stock market listing. Other expenses, comprising the costs incurred for business development, marketing and commercial market supply, were EUR 0.1 million, the same as in the previous year. The Heidelberg Pharma Group s net loss for the first three months of the fiscal year increased to EUR 6.3 million, as planned (previous year: EUR 4.6 million). Basic earnings per share based on the weighted average number of shares issued during the reporting period fell from EUR -0.16 in the previous year to EUR -0.20 in the reporting quarter as a

Heidelberg pharmaTradegate exchangeEnglish companyHeidelberg pharma groupInvestors financial reportsNews serviceFrankfurt stock exchangeDistribution servicesExecutive managementExecutive management board roundingCorporate communicationsKatja arnoldSylvia wimmerManaging directorAntibody targeted amanitin conjugateCorporate news